Cellular Efflux Pump and Interaction between Cisplatin and Paclitaxel in Ovarian Cancer Cells

Publisher： Karger

E-ISSN： 1423-0232|59|4|329-335

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.4, 2000-11, pp. : 329-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel in Cisplatin or Carboplatin-Pretreated Ovarian Cancer

By  

Oncology, Vol. 55, Iss. 3, 1998-04 ,pp. : 228-234

Karger

Access to resources Recommend Favorite

Cellular uptake and antitumour activity of paclitaxel incorporated into trilaurin-based solid lipid nanoparticles in ovarian cancer

By Xu Wenting   Lim Soo-Jeong   Lee Mi-Kyung  

Journal of Microencapsulation, Vol. 30, Iss. 8, 2013-12 ,pp. : 755-761

Informa Healthcare

Access to resources Recommend Favorite

Intracellular ATP-Binding Cassette Transporter A3 is Expressed in Lung Cancer Cells and Modulates Susceptibility to Cisplatin and Paclitaxel

By  

Oncology, Vol. 84, Iss. 6, 2013-05 ,pp. : 362-370

Karger

Access to resources Recommend Favorite

CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 2, 2015-01 ,pp. : 340-348

Spandidos Publications

Access to resources Recommend Favorite

Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 19-23

Karger

Access to resources Recommend Favorite